Triglycerides: Understanding Your Blood Test Series

1. Overview: What this test reveals and why it is important

Triglycerides are the main form of fat stored in the body and the most abundant dietary fat. They consist of three fatty acids attached to a glycerol backbone. In the bloodstream, triglycerides are carried within chylomicrons (from dietary fat) and very‑low‑density lipoproteins (VLDL, synthesised by the liver).

A triglyceride measurement reflects the balance between energy intake, energy expenditure, and hepatic fat metabolism. Elevated triglycerides (hypertriglyceridaemia) are common and often accompany obesity, insulin resistance, and excess alcohol intake. Very high levels (≥500 mg/dL, 5.6 mmol/L) increase the risk of acute pancreatitis. Moderate elevations are associated with increased cardiovascular risk, particularly when combined with low HDL and high small‑dense LDL.

Triglycerides are highly variable and respond rapidly to diet and lifestyle. They are therefore a sensitive marker of metabolic health and a modifiable target for intervention.

---

2. What does it measure

a. Units of measurement

· Milligrams per decilitre (mg/dL) – standard in the United States

· Millimoles per litre (mmol/L) – used in many other countries (divide mg/dL by 88.57)

b. Normal Range and Risk Classification

(Reference ranges vary by laboratory; cardiovascular risk categories are based on fasting levels.)

Fasting triglyceride levels (adults):

· Normal: less than 150 mg/dL (1.7 mmol/L)

· Borderline high: 150–199 mg/dL (1.7–2.2 mmol/L)

· High: 200–499 mg/dL (2.3–5.6 mmol/L)

· Very high: 500 mg/dL or greater (≥5.7 mmol/L) – pancreatitis risk

Children and adolescents (fasting):

· Normal: less than 90 mg/dL (1.0 mmol/L)

· Borderline high: 90–129 mg/dL (1.0–1.4 mmol/L)

· High: ≥130 mg/dL (≥1.5 mmol/L)

Interpretation notes:

· Non‑fasting triglycerides are normally higher (by 20–30 mg/dL) and can be used for screening; however, classification and treatment decisions generally rely on fasting levels (8–12 hours).

· Extreme elevations (≥1000 mg/dL) are usually due to combined genetic and secondary factors and confer imminent pancreatitis risk.

· Triglycerides fluctuate more than cholesterol; two or three measurements are advisable before making major therapeutic decisions.

· Elevated triglycerides are a component of the metabolic syndrome (along with central obesity, low HDL, hypertension, and impaired fasting glucose).

---

3. Other factors connected to this

a. Direct correlation (factors that directly raise triglycerides)

Dietary and lifestyle factors:

· Excess alcohol intake – even moderate regular drinking can elevate triglycerides; heavy intake causes marked elevation.

· Refined carbohydrates and added sugars – particularly fructose (from soft drinks, fruit juices, sweets) directly increases hepatic VLDL production.

· High glycaemic load diets – rapid glucose absorption stimulates insulin secretion, which promotes triglyceride synthesis.

· Sedentary lifestyle / physical inactivity – reduces clearance of triglyceride‑rich lipoproteins.

· Obesity, especially visceral adiposity – increased free fatty acid flux to liver.

Genetic disorders:

· Familial combined hyperlipidaemia – elevated triglycerides and/or LDL.

· Familial hypertriglyceridaemia – isolated triglyceride elevation, often moderate.

· Lipoprotein lipase (LPL) deficiency – severe hypertriglyceridaemia (chylomicronaemia syndrome), usually presents in childhood.

· Apolipoprotein C‑II deficiency – impaired LPL activation.

· Familial dysbetalipoproteinaemia (type III hyperlipoproteinaemia) – elevated triglycerides and cholesterol, palmar xanthomata, APOE2/E2 genotype.

Secondary causes:

· Type 2 diabetes / insulin resistance – impaired LPL activity, increased VLDL secretion.

· Hypothyroidism – reduced LPL activity.

· Chronic kidney disease / nephrotic syndrome – altered lipoprotein metabolism.

· Pregnancy – physiological rise (up to 2–3 fold) in third trimester.

· Medications:

· Increase triglycerides: thiazide diuretics, beta‑blockers (non‑vasodilating), oral oestrogens, tamoxifen, glucocorticoids, isotretinoin, atypical antipsychotics (clozapine, olanzapine), protease inhibitors, ciclosporin.

· Bile acid sequestrants may raise triglycerides.

Other:

· Acute stress / illness – triglycerides may rise transiently; defer testing.

· Glycogen storage diseases – type I.

b. Indirect correlation (factors that influence triglyceride interpretation or cause artefactual changes)

· Fasting status: essential for accurate classification. Non‑fasting triglycerides are typically 20–50 mg/dL higher; repeat fasting if non‑fasting level >200 mg/dL.

· Pregnancy: triglycerides rise progressively; testing should be deferred until ≥6 weeks postpartum unless urgent.

· Acute illness / myocardial infarction / surgery: triglycerides fall initially, then may rise; wait 4–6 weeks.

· Alcohol abstinence: triglycerides decrease within days; advise patient to maintain usual alcohol intake before testing.

· Body weight: recent weight loss lowers triglycerides; stable weight is ideal for baseline.

· Medications: as above.

· Assay interference: gross hypertriglyceridaemia can cause lipaemic serum, interfering with other tests (e.g., amylase, electrolytes).

· Seasonal variation: modest winter increase.

· Ethnicity: South Asians have higher triglycerides for same degree of insulin resistance.

---

4. Disorders related to abnormal values

a. When triglycerides are elevated (hypertriglyceridaemia)

Mild to moderate (150–499 mg/dL):

· Metabolic syndrome, obesity, type 2 diabetes.

· Excess alcohol intake.

· High‑carbohydrate / high‑sugar diet.

· Hypothyroidism, chronic kidney disease.

· Familial combined hyperlipidaemia, familial hypertriglyceridaemia.

· Medications (as above).

Severe (≥500 mg/dL) and very severe (≥1000 mg/dL):

· Pancreatitis risk – acute pancreatitis can occur, especially when triglycerides >1000 mg/dL.

· Lipoprotein lipase deficiency, apolipoprotein C‑II deficiency – present in childhood; eruptive xanthomata, lipaemia retinalis.

· Familial hypertriglyceridaemia with secondary exacerbation (poorly controlled diabetes, alcohol, oestrogens).

· Type III hyperlipoproteinaemia (dysbetalipoproteinaemia) – often moderate‑severe, with characteristic lipid profile.

b. When triglycerides are low (hypotriglyceridaemia – usually benign)

· Malnutrition / malabsorption – coeliac disease, short bowel syndrome, cystic fibrosis.

· Hyperthyroidism – increased LPL activity.

· Abetalipoproteinaemia / familial hypobetalipoproteinaemia – extremely low triglycerides, absent APO B.

· Advanced liver disease – reduced VLDL synthesis.

· Medications: high‑dose omega‑3, fibrates, niacin (therapeutic).

· Genetic: rare LPL gene variants with enhanced activity.

Interpretation note: Isolated low triglycerides in an asymptomatic person are usually of no concern; investigate if accompanied by malnutrition, diarrhoea, or neurological symptoms.

---

5. Best way to address aberrant levels

Important principle: Triglycerides are exquisitely sensitive to lifestyle. Dietary modification, weight loss, exercise, and alcohol restriction are the cornerstones of management. Pharmacotherapy is reserved for those at high risk of pancreatitis (triglycerides ≥500 mg/dL despite lifestyle) and sometimes for cardiovascular risk reduction in patients with persistent moderate hypertriglyceridaemia and established ASCVD or diabetes.

a. Quick ways or using Medications

For severe hypertriglyceridaemia (≥500 mg/dL) – pancreatitis prevention:

· Fibrates:

· Fenofibrate – first‑line; lowers triglycerides by 30–50%.

· Gemfibrozil – less preferred due to interaction with statins (increased myopathy risk).

· Omega‑3 fatty acids (prescription):

· Icosapent ethyl – purified EPA ethyl ester; lowers triglycerides by 20–30%.

· Caution: Most prescription omega‑3 is fish‑derived; prefer algal EPA/DHA if available, though evidence base for cardiovascular benefit is strongest for icosapent ethyl. In severe hypertriglyceridaemia, discuss with physician; ecological considerations must be balanced against immediate pancreatitis risk.

· Statins:

· Modest triglyceride reduction (10–20%) in proportion to baseline level; not first‑line for isolated hypertriglyceridaemia but indicated if concomitant elevated LDL or ASCVD risk.

For moderate hypertriglyceridaemia (150–499 mg/dL) – cardiovascular risk reduction:

· Statins – primary therapy if LDL is above goal; triglyceride reduction is a secondary benefit.

· Icosapent ethyl – in patients with diabetes or ASCVD and triglycerides 135–499 mg/dL despite statin, reduces cardiovascular events (REDUCE‑IT).

· Fibrates – may be added in high‑risk patients with persistent hypertriglyceridaemia, though cardiovascular outcome benefit is modest.

For secondary causes:

· Treat hypothyroidism (levothyroxine), improve glycaemic control (metformin, insulin), disoffending medications if possible.

Do not self‑prescribe fibrates or prescription omega‑3; all require medical supervision.

b. Using Supplements or Holistic medicine

Supplements with evidence for triglyceride lowering:

· Omega‑3 fatty acids (EPA/DHA):

· Dose‑dependent reduction; 2–4 g/day lowers triglycerides by 20–40%.

· Preferred source: Algae oil – sustainable, plant‑based, direct EPA/DHA, no marine contaminants.

· Avoid conventional fish oil (overfishing, ocean pollution, ethical concerns).

· Form: re‑esterified triglyceride form for optimal absorption.

· Caution: May increase LDL‑C in some patients; monitor.

· Berberine:

· Reduces triglycerides by 15–25% in meta‑analyses; improves insulin sensitivity.

· Preferred source: Standardised berberine (≥97%) from Berberis aristata or Phellodendron amurense.

· Dose: 500 mg twice daily.

· Caution: GI side effects, drug interactions (statins, cyclosporine, anticoagulants); avoid in pregnancy.

· Soluble fibre:

· Psyllium (10 g/day), beta‑glucans (oats, barley), glucomannan – modest triglyceride reduction (5–10%).

· Preferred sources: oat bran, psyllium husk, barley.

· Green tea extract (EGCG):

· Modest triglyceride lowering (5–10%) in some meta‑analyses.

· Use beverage (2–3 cups/day) rather than concentrated extracts (hepatotoxicity risk).

· Garlic (Allium sativum):

· Aged garlic extract; small triglyceride reduction.

· Curcumin (turmeric):

· Anti‑inflammatory; some studies show modest triglyceride reduction.

· Use phytosomal, liposomal, or with piperine for bioavailability.

· Vitamin D:

· Deficiency linked to hypertriglyceridaemia; supplementation may improve lipid profile in deficient individuals.

· Preferred: D3 (cholecalciferol) from lichen.

· Magnesium:

· Deficiency associated with hypertriglyceridaemia; supplementation may modestly improve levels.

· Preferred forms: glycinate, citrate, malate.

· Chromium:

· Controversial; may improve insulin sensitivity; weak triglyceride effect.

Supplements with limited or no evidence for triglyceride lowering:

· Niacin – lowers triglycerides but no longer recommended due to side effects and lack of outcome benefit.

· Plant sterols/stanols – primarily LDL‑C lowering; minimal triglyceride effect.

Ayurvedic approaches:

· Guggulu (Commiphora mukul):

· Standardised guggulsterones; may modestly lower triglycerides, but efficacy debated and hepatotoxicity concerns.

· Arjuna (Terminalia arjuna):

· Limited evidence for lipid lowering.

· Fenugreek (Trigonella foenum‑graecum):

· Seeds; soluble fibre content may reduce triglycerides.

· Always consult a qualified practitioner; herbs can interact with medications.

Supplements to avoid:

· Products with added synthetic folic acid or cyanocobalamin – use methylfolate and methylcobalamin if needed.

· Unregulated herbal blends with undisclosed ingredients.

c. Using Diet and Foods (following a plant‑forward, ecologically sustainable approach)

Diet is the most potent intervention for hypertriglyceridaemia. A reduction of 20–50% is achievable with consistent dietary modification.

Core dietary principles – what to emphasise:

· Reduce total carbohydrate intake, especially refined carbohydrates and added sugars:

· Fructose restriction is critical – eliminate sugary beverages (soft drinks, fruit juices, sweetened teas), sweets, pastries.

· Replace refined grains (white bread, white rice, pasta) with whole grains (oats, barley, quinoa, brown rice, millets).

· Limit added sugars to less than 5–10% of total energy.

· Replace saturated fats with unsaturated fats:

· Extra virgin olive oil – principal fat.

· Nuts and seeds – walnuts, almonds, flaxseeds, chia seeds, hemp seeds.

· Avocado.

· Increase omega‑3 fatty acids:

· ALA sources: ground flaxseeds, chia seeds, hemp seeds, walnuts.

· Direct EPA/DHA: microalgae (spirulina, chlorella – limited amounts); algae oil supplements for therapeutic doses.

· Increase soluble fibre:

· Oats, barley, psyllium, eggplant, okra, legumes (lentils, chickpeas, beans).

· Target ≥30 g total fibre daily, with 10–20 g soluble fibre.

· Achieve and maintain healthy weight:

· Weight loss of 5–10% reduces triglycerides by 20–30%.

· Alcohol:

· Complete abstinence if triglycerides are elevated, especially if >200 mg/dL. Even small amounts can exacerbate hypertriglyceridaemia.

Specific foods with evidence for triglyceride lowering:

· Oats and barley: beta‑glucan – 3 g/day.

· Legumes: lentils, chickpeas, beans – ½ cup daily.

· Nuts: 30 g/day – walnuts, almonds.

· Soy protein: tofu, tempeh, edamame – 25 g/day.

· Fatty fish alternatives: not applicable – use algae oil supplements for EPA/DHA.

· Green tea: 2–3 cups/day.

· Chilli peppers: capsaicin may modestly lower triglycerides.

· Garlic, onions: organosulfur compounds.

What to avoid or severely limit:

· Added sugars and high‑fructose corn syrup – soft drinks, fruit juices, sweets, ice cream, commercial baked goods.

· Refined carbohydrates – white bread, white rice, pasta, sugary cereals.

· Excess alcohol – zero is optimal.

· Trans fats – partially hydrogenated oils.

· Saturated fats – butter, cream, cheese, fatty meats, palm oil, coconut oil.

Protein sources (hierarchy adhered):

· Plant‑based (primary): legumes, soy products (tofu, tempeh, edamame), seitan.

· Fungi / algae (encouraged): mycoprotein (Quorn), spirulina, chlorella.

· Biotechnology / lab‑grown (acceptable): precision‑fermented dairy proteins (animal‑free whey, casein).

· Dairy / eggs (permitted but not emphasised): low‑fat fermented dairy (yoghurt, kefir) if tolerated; full‑fat dairy contains saturated fat.

· Meat, poultry, fish: deliberately omitted. Effective plant‑based alternatives exist to meet all nutritional requirements for triglyceride management. There is no need for animal products to achieve normal triglyceride levels.

---

6. How soon can one expect improvement and the ideal time frame to retest

Triglycerides respond rapidly to lifestyle and pharmacotherapy – within days to weeks.

For dietary and lifestyle interventions:

· Carbohydrate / sugar restriction: Triglycerides begin to fall within 3–7 days; maximal reduction (20–40%) by 4–6 weeks.

· Weight loss: 5–10% weight loss reduces triglycerides by 20–30% over 3–6 months.

· Alcohol abstinence: Triglycerides decline within 3–7 days; full effect in 2–4 weeks.

· Exercise: Acute bout lowers triglycerides post‑exercise; sustained training reduces fasting triglycerides in 4–12 weeks.

For supplements:

· Omega‑3 (algae oil): 2–4 g/day reduces triglycerides within 4–8 weeks.

· Berberine: triglyceride reduction detectable in 4–8 weeks.

· Soluble fibre: 4–8 weeks.

For medications:

· Fibrates: triglyceride reduction within 2–4 weeks; maximal effect at 6–8 weeks.

· Icosapent ethyl: 4–8 weeks.

· Statins: modest reduction at 6–8 weeks.

Retesting interval:

· Severe hypertriglyceridaemia (≥500 mg/dL): repeat fasting lipid panel in 4–8 weeks after lifestyle and/or medication initiation. If triglycerides remain ≥1000 mg/dL, immediate medical follow‑up for pancreatitis prevention.

· Moderate hypertriglyceridaemia (150–499 mg/dL): repeat in 8–12 weeks after intervention.

· At goal: annually, or more frequently if clinical status changes.

· Do not retest more often than every 4 weeks unless monitoring acute pancreatitis risk.

---

Conclusion

Triglycerides are the metabolic mirrors of our modern lifestyle – reflecting excess sugar, refined starch, alcohol, and sedentary time more faithfully than any other lipid parameter. They are also the most rapidly responsive to change.

The therapeutic arc is clear: subtract the sugars, add the fibre, move the body, lose the weight. When these fail or when levels threaten the pancreas, fibrates and omega‑3s are highly effective. But no pill substitutes for a diet that does not overwhelm the liver's capacity to process energy.

A plant‑based, ecologically responsible diet – whole grains, legumes, nuts, seeds, and algae‑derived omega‑3s – is the ideal prescription for hypertriglyceridaemia. It is low in saturated fat, free of cholesterol, rich in fibre, and devoid of the concentrated fructose that drives hepatic fat synthesis. Meat is not only unnecessary; its displacement by plants is itself therapeutic.

Triglycerides are a warning. Heed it early, and the response will be swift.

---x---x

Note on dietary recommendations on this site:

For the sake of our environment we adhere to the following dietary preference hierarchy:

1. Plant‑based

2. Fungi / algae / fermented

3. Biotechnology / lab‑grown / cultures

4. Dairy / eggs

5. Meat / fish / poultry (only if no effective alternative exists)

This approach reflects ecological responsibility, antibiotic stewardship, and the urgent need to reduce the environmental footprint of dietary recommendations.

-x-x